Galderma Group AG reported record net sales of $3.737 billion for the first nine months of the year, representing net sales growth of 15.0% at constant currency. This despite challenging market dynamics, driven primarily by volume growth complemented by favorable mix. “Galderma’s strong performance in the first nine months of 2025 demonstrates the breadth of our portfolio and our ability to deliver growth through innovation, commercial excellence, and global expansion,” said Ornskov Flemming,...